IQ-AI Limited Update - IB Stroke (0713U)
July 27 2020 - 2:00AM
UK Regulatory
TIDMIQAI
RNS Number : 0713U
IQ-AI Limited
27 July 2020
IQ-AI Ltd
("IQ-AI" or the "Company")
Update - IB Stroke(TM)
In November 2019, IQ-AI announced the addition of IB Stroke to
its product roadmap. As a logical extension of its current
portfolio of proven neuro products, IB Stroke has the advantage of
leveraging existing FDA cleared and CE marked algorithms to rapidly
generate information commonly used in the diagnosis of stroke in
patients. The team at IQ-AI's subsidiary, Imagining Biometrics
("IB") is pleased to announce that the development of IB Stroke is
on track. In addition, a subcommittee of the USA Jumpstarting Brain
Tumour Drug Development Coalition has recently recommended that the
quantitative perfusion capability, exclusive to IB, provides a
singular foundation upon which to build IB Stroke and is now the
consensus recommended standard for the National Clinical Trials
Network.
The technology will first be made available as part of a
streamlined workflow within IB Rad Tech and is on target to be
released in early Q4. IB Rad Tech harnesses the power of the
individual software modules and combines them into customised and
efficient workflows. Along with IB Neuro, IB Diffusion and IB Delta
Suite will also be part of the overall IB Stroke workflow within IB
Rad Tech. As the final stages of software development are
completed, IB Stroke will begin software validation testing as
required for regulatory compliance and commercial distribution. IB
recently passed their annual ISO 13485:2016 recertification audit;
an international quality standard and pre-requisite for European
distribution.
IB is pleased to announce the appointment of Dr. Vasileios .
Katsaros, MD, PhD to the IB team, as key opinion leader and
collaborator. Dr. Katsaros holds positions including Consultant
Radiologist - Neuroradiologist, Department of Advanced Imaging
Modalities (MRI Unit) of General Anti-Cancer and Oncological
Hospital of Athens "St. Savvas" and Research Affiliate in the
Departments of Neurosurgery and Neurology, National and
Kapodistrian University of Athens and the Department of
Neuroradiology, University College of London (UCL).
"I have been using IB Software for several years and I am highly
confident in the underlying science of their products," said Dr.
Katsaros. "The streamlined workflows available in IB Rad Tech
simplify and automate the processing of sophisticated maps and I am
pleased to offer feedback for the IB Stroke workflow," added Dr.
Katsaros.
The Directors of the Company accept responsibility for the
contents of this announcement.
-ENDS-
For further information, please contact:
IQ-AI Limited
Trevor Brown/Vinod Kaushal/Qu Li
Tel: 020 7469 0930
----------------------------------------------------------
Peterhouse Capital Limited (Financial Adviser and Broker)
Lucy Williams/Heena Karani
Tel: 020 7220 9797
----------------------------------------------------------
ABOUT Imaging Biometrics , LLC
Imaging Biometrics(R), a subsidiary of IQ-AI Limited (LON:IQAI),
develops and provides visualisation and analytical solutions that
enable clinicians to better diagnose and treat disease with greater
confidence. Through close collaboration with top researchers and
clinicians, sophisticated advancements are translated into
platform-independent and automated software plug-ins which can
extend the base functionality of workstations, imaging systems,
PACS, or medical viewers. By design, IB's advanced visualisation
software seamlessly integrates into routine workflows. For more
information about Imaging Biometrics, visit the company's website
at www.imagingbiometrics.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
STRUSUVRRSUBUAR
(END) Dow Jones Newswires
July 27, 2020 02:00 ET (06:00 GMT)
Iq-ai (LSE:IQAI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Iq-ai (LSE:IQAI)
Historical Stock Chart
From Sep 2023 to Sep 2024